YBX1 and gastric cancer: It was observed that CJP–TiN demonstrated a significant efficacy in the PDT of GC, offering a promising new treatment option for advanced GC, which primarily relies on systemic chemotherapy.[38] Existing research indicates that PANoptosis, similar to other forms of cell death, can induce tumor cell death and suppress tumor progression, thereby rendering it a promising target for cancer therapy.[39] Lin et al.[40] found that YBX1 promotes tumor cell growth and inhibits PANoptosis in AGS cells.